Page last updated: 2024-11-03

praziquantel and Hepatitis D

praziquantel has been researched along with Hepatitis D in 1 studies

azinox: Russian drug

Hepatitis D: INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS, a defective RNA virus that can only infect HEPATITIS B patients. For its viral coating, hepatitis delta virus requires the HEPATITIS B SURFACE ANTIGENS produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Patel, J1
Ali, M1

Other Studies

1 other study available for praziquantel and Hepatitis D

ArticleYear
Hydatid cyst: hepatitis B and D coinfection accelerating the course of the disease.
    BMJ case reports, 2017, Mar-06, Volume: 2017

    Topics: Adult; Albendazole; Anthelmintics; Bile Ducts, Intrahepatic; Cholangitis; Coinfection; Disease Progr

2017